SpringerLink
Log in

Intermediate-Risk Childhood Acute Lymphoblastic Leukemias: Amsacrine + Cytosine Arabinoside Versus Intermediate-Dose Methotrexate for Consolidation, and 6-Mercaptopurine + Methotrexate + Vincristine Versus Monthly Pulses for Maintenance

  • Conference paper
Acute Leukemias

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 30))

Abstract

The prognosis for childhood acute lymphoblastic leukemia improved dramatically in the late 1970s, with 50%–70% of long-term survivors being reported following multiagent chemotherapy regimens. Unfortunately, the survival rate is still poor for relapsing patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. D Coccia PF, Blayer WA, Siegel SE, Cross S, Sather HN, Hammond LD (1981) Reduced therapy for children with good prognosis acute lymphoblastic leukemia. Blood [Suppl] 58: 1370

    Google Scholar 

  2. Moe PS, Seip M, Finne PH (1981) Intermediate dose of methotrexate in childhood acute leukemia in Norway. Acta Paediatr Scan 70–73

    Google Scholar 

  3. Riehm H, Sadner H, Henze G, Kornhuber P, Langermann HJ, Muller-Weirich S, Schellong G (1983) Acute lymphoblastic leukemia: treatment, results in three BFM studies. In: Murphy SB, Gilbert IR (eds) Leukemia research advances in cell biology and treatment. Elsevier, Amsterdam, p 251

    Google Scholar 

  4. Weil M, Auclerc MF, Schaison G, Auclerc G, Daubrisson A, Degos L (1982) Activité clinique de la m Amsa et de l’association m Amsa et de Cytosine Arabinoside. Presse Med 11: 2911

    CAS  Google Scholar 

  5. Schaison G, Jacquillat Cl, Weil M, Marty M, Harousseau JL, Bancillon A, Boiron M (1983) Treatment of very increased risk childhood acute lymhoblastic leukemia: good results of an aggressive protocol. Am Soc Clin Oncol Abstract 662, p 170

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hôpital Saint-Louis, Paris, France

    G. Schaison, G. Leverger, A. Bancillon, M. Marty, D. Olive, G. Cornu, C. Griscelli, S. Lemerle, J. L. Harousseau, M. Bonnet, F. Freycon, D. Dufillot, M. Demeocq, F. Bauters, J. P. Lamagnere & O. Taboureau

  2. French Cooperative Group, France

    G. Schaison, G. Leverger, A. Bancillon, M. Marty, D. Olive, G. Cornu, C. Griscelli, S. Lemerle, J. L. Harousseau, M. Bonnet, F. Freycon, D. Dufillot, M. Demeocq, F. Bauters, J. P. Lamagnere & O. Taboureau

Authors
  1. G. Schaison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Leverger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Bancillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Marty
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Olive
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Cornu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Griscelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Lemerle
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. L. Harousseau
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F. Freycon
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. D. Dufillot
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M. Demeocq
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. F. Bauters
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. J. P. Lamagnere
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. O. Taboureau
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Internal Medicine and Pediatrics, University of Münster, Albert-Schweitzer-Strasse 33, D-4400, Münster, Federal Republic of Germany

    T. Büchner , G. Schellong , W. Hiddemann , D. Urbanitz  & J. Ritter , , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schaison, G. et al. (1987). Intermediate-Risk Childhood Acute Lymphoblastic Leukemias: Amsacrine + Cytosine Arabinoside Versus Intermediate-Dose Methotrexate for Consolidation, and 6-Mercaptopurine + Methotrexate + Vincristine Versus Monthly Pulses for Maintenance. In: Büchner, T., Schellong, G., Hiddemann, W., Urbanitz, D., Ritter, J. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71213-5_81

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71213-5_81

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16556-9

  • Online ISBN: 978-3-642-71213-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation